4.7 Article

Improved Liver Delivery of Primaquine by Phospholipid-Free Small Unilamellar Vesicles with Reduced Hemolytic Toxicity

期刊

MOLECULAR PHARMACEUTICS
卷 19, 期 6, 页码 1778-1785

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.molpharmaceut.1c00520

关键词

phospholipid-free small unilamellar vesicles (PFSUVs); primaquine (PQ); red blood cells (RBCs); liver targeting; liver-stage malaria

资金

  1. Canadian Institutes of Health Research (CIHR) [PJT-148610, PJT-168861]
  2. Natural Science and Engineering Research Council in Canada (NSERC) [RGPIN-2017-03787]
  3. Canada Foundation for Innovation (CFI) [35816]
  4. Mitacs Accelerate grant - Mitacs [IT13402]
  5. Mitacs and Precision Nanosystems Inc., Canada [18004]
  6. King Abdulaziz City for Science and Technology (KACST) in Saudi Arabia
  7. German Research Foundation (DFG) [423802991]
  8. Swiss National Science Foundation Postdoc Mobility Fellowship [183923]

向作者/读者索取更多资源

The study demonstrated that phospholipid-free small unilamellar vesicles composed of Tween80 and cholesterol could effectively encapsulate and deliver primaquine (PQ) to hepatocytes, reducing exposure to red blood cells and hemolytic toxicity. This approach showed potential in improving the efficacy of PQ for treating liver-stage malaria.
Hemolytic toxicity caused by primaquine (PQ) is ahigh-risk condition that hampers the wide use of PQ to treat liver-stage malaria. This study demonstrated that phospholipid-freesmall unilamellar vesicles (PFSUVs) composed of Tween80 andcholesterol could encapsulate and deliver PQ to the hepatocyteswith reduced exposure to the red blood cells (RBCs). Nonionicsurfactant (Tween80) and cholesterol-forming SUVs with a meandiameter of 50 nm were fabricated for delivering PQ. Drug release/retention, drug uptake by RBCs, pharmacokinetics, and liveruptake of PFSUVs-PQ were evaluated inin vitroandin vivomodelsin comparison to free drugs. Additionally, the stress effect on RBCsinduced by free PQ and PFSUVs-PQ was evaluated by examiningRBC morphology. PFSUVs provided >95% encapsulationefficiency for PQ at a drug-to-lipid ratio of 1:20 (w/w) and stably retained the drug in the presence of serum. When incubatedwith RBCs, PQ uptake in the PFSUVs group was reduced by 4- to 8-folds compared to free PQ. As a result, free PQ inducedsignificant RBC morphology changes, while PFSUVs-PQ showed no such adverse effect. Intravenously (i.v.) delivered PFSUVs-PQproduced a comparable plasma profile as free PQ, given i.v. and orally, while the liver uptake was increased by 4.8 and 1.6-folds,respectively, in mice. Within the liver, PFSUVs selectively targeted the hepatocytes, with no significant blood or liver toxicity in mice.PFSUVs effectively targeted PQ to the liver and reduced RBC uptake compared to free PQ, leading to reduced RBC toxicity.PFSUVs exhibited potential in improving the efficacy of PQ for treating liver-stage malaria.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据